Stage I and II Hodgkin's disease in the pediatric population: Long-term follow-up of patients staged predominantly clinically

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 19, Issue 2, 1996, Pages 174-178

  Rock, Douglas B ^a   Murray, Kevin J ^b   Schultz, Christopher J ^c   Lauer, Stephen J ^b   Wilson, J Frank ^c  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c Medical College of Wisconsin ^*

Author keywords

Chemotherapy; Combined modality therapy; Pediatric Hodgkin's disease; Radiotherapy; Staging laparotomy

Indexed keywords

ADOLESCENT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; FEMALE; HODGKIN DISEASE; HUMAN; MALE; STATISTICAL ANALYSIS;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; BONE MARROW; CHILD; COHORT STUDIES; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GALLIUM RADIOISOTOPES; HODGKIN DISEASE; HUMANS; LAPAROTOMY; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, HIGH-ENERGY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0029986772     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199604000-00017     Document Type: Article

References (16)

1. Donaldson SS. Hodgkin's disease in children. Semin Oncol 1990;17:736-48.
2. Maity A, Goldwein JW, Lange B, D'Angio GJ. Comparison of high-dose and low-dose radiation with and without chemotherapy for children with Hodgkin's disease: an analysis of the experience at the Children's Hospital of Philadelphia and the Hospital of the University of Pennsylvania. J Clin Oncol 1992;10:929-35.
3. Dionet C, Oberlin O, Habrand JL, et al. Initial chemotherapy and low-dose radiation in limited fields in childhood Hodgkin's disease: results of a joint cooperative study by the French Society of Pediatric Oncology (SFOP) and Hopital Saint-Louis, Paris. Int J Radiat Oncol Biol Phys 1988;15:341-6.
4. Donaldson SS, Link MP. Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease. J Clin Oncol 1987;5:742-9.
5. Hudson MM, Greenwald C, Thompson E, et al. Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease. J Clin Oncol 1993;11:100-8.
6. Gehan EA, Sullivan MP, Fuller LM, et al. The intergroup Hodgkin's disease in children. A study of stages I and II. Cancer 1990;65:1429-37.
7. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 1971;31:1860-1.
8. Rock DB, Schultz CJ, Murray KJ, Wilson JF, Cox JD. Continuous split course irradiation for stage I and II Hodgkin's disease: 20 year experience at the Medical College of Wisconsin. Radiother Oncol 1994;30:222-6.
9. Winchester DP, Cox JD. Standards for breast-conservation treatment. A Cancer J Clin 1992;42:134-62.
10. Lee ET, Desu MM. A computer program for comparing K samples with right-censored data. Comp Prog Biomed 1972;2: 315-21.
11. Green DM, Ghoorah J, Douglass H Jr, et al. Staging laparotomy with splenectomy in children and adolescents with Hodgkin's disease. Cancer Treat Rev 1983;10:23-38.
12. Donaldson SS, Kaplan HS. Complications of treatment of Hodgkin's disease in children. Cancer Treat Rev 1982;66: 977-89.
13. Jenkin RD, Brown TC, Peters MV, Sonley MJ. Hodgkin's disease in children. A retrospective analysis: 1958-73. Cancer 1975;35: 979-90.
14. Donaldson SS. Making choices in the staging of children with Hodgkin's disease [Comment]. Med Pediatr Oncol 1991;19: 211-3.
15. Jenkin D, Doyle J. Pediatric Hodgkin's disease. Later results and toxicity - the Toronto experience. Cancer Treat Res 1989;41: 247-56.
16. Donaldson SS, Whitaker SJ, Plowman PN, Link MP, Malpas JS. Stage I-II pediatric Hodgkin's disease: long-term follow-up demonstrates equivalent survival rates following different management schemes. J Clin Oncol 1990;8:1128-37.